Basic Information
MGB Biopharma is a biopharmaceutical company aimed at developing a new class of anti-infective drugs based on DNA minor groove binders (MGB). The company has an experienced team from the pharmaceutical and biotechnology fields and is committed to developing small molecules with specific antibacterial effects against resistant bacteria.
MGB Biopharma
United Kingdom
less than 15 people
January 01, 2009
enquiries@mgb-biopharma.com

